Tag: donanemab
-
What’s next for embattled Alzheimer’s drug aducanamab?
At a J.P. Morgan Healthcare panel on January 11, representatives for Biogen cited Eli Lilly’s positive Phase 2 study of Alzheimer’s drug donanemab […]
-
Positive Phase 2 results for Alzheimer’s drug donanemab
On January 10, pharmaceutical giant Eli Lilly announced positive results in a Phase 2 trial of donanemab, a monoclonal antibody targeting the amyloid-β […]